Summary of P3 Health Partners Q2 2026 Earnings Call

1Key Financial Results and Metrics

Adjusted EBITDA: $54 million for Q2, contributing to a total of $80 million for the first half of 2026, a significant improvement from a loss of $39 million in the first half of 2025.

Revenue: $386 million for Q2, up from $356 million in Q2 2025, despite a decrease in membership.

Medical Claims Expense: $269 million, including $45 million from favorable payer settlements and prior year developments.

Medical Loss Ratio: 85.6% after adjustments.

Membership: Approximately 105,000 at-risk members, down from 116,000 in Q2 2025, reflecting strategic exits from less profitable arrangements.

Cash Position: Ended the quarter with $21 million in cash and equivalents.

2Strategic Updates and Business Highlights

Operational Execution: Continued focus on medical cost management, quality execution, and provider engagement. Enhanced point-of-care tools are now reaching over 65,000 lives, improving care gap closures.

Quality Performance: Tracking ahead of internal goals towards achieving a 4-star rating on HEDIS and medication adherence measures.

Payer Partnerships: Strengthened risk-sharing arrangements and improved funding mechanisms with key payer partners, leading to favorable settlements.

Growth Strategy: Progressing positively in Nebraska, with plans to expand clinical and operational infrastructure before moving to full risk arrangements in 2028.

3Forward Guidance and Outlook

Revised Full-Year 2026 Outlook: Adjusted EBITDA guidance raised to a range of $80 million to $110 million, with a midpoint of $95 million. This reflects improved operational performance and favorable contractual settlements.

Seasonal Considerations: Acknowledgment of typical seasonal increases in medical expenses in the second half of the year, with active management strategies in place.

4Bad News, Challenges, or Points of Concern

Membership Decline: Year-over-year decrease in at-risk membership due to strategic exits from non-performing contracts, which could impact future revenue.

Seasonality of Earnings: Anticipated pressure on medical expenses in the latter half of the year, which may affect profitability.

Market Exits by Competitors: Potential impact on membership from broader market exits by other plans, though management believes this will not significantly affect their current membership.

5Notable Q&A Insights

Payer Settlements: Clarified that $41 million of the $45 million favorable settlements in Q2 were related to prior period developments and did not affect revenue, only medical claims expense.

Future Pricing and Membership Impact: Management indicated uncertainty regarding how upcoming benefit designs for 2027 will affect membership but does not expect major impacts from planned market exits.

Point-of-Care Tools: High adoption rates among Tier 1 providers, with ongoing efforts to expand usage among Tier 2 providers, indicating positive feedback and engagement from the clinical community. This summary encapsulates the key points from P3 Health Partners' Q2 2026 earnings call, highlighting financial performance, strategic initiatives, and future outlook while addressing potential challenges.